For Patients

Get Illness/Condition Information

The FDA's Office of Health and Constituent Affairs (OHCA) is working with you to bring the patient advocate's perspective into the review of new drugs to treat all diseases and disorders including but not limited to cancer, cardiovascular disease, diabetes, Hepatitis B/C and HIV/AIDS.

CELP - The Cardiovascular
and Endocrine Liaison Program


Learn more about the Office of Health and Constituent Affairs - CELP program.

The OHCA Patient Liaison Team meet regularly with organized patient advocacy groups to talk about their concerns about drug and device development and to assist them in understanding the FDA drug and device regulatory process.

We also respond to telephone calls and emails from you to answer your questions about clinical trials,drug development, expanded access and medical product safety.

Medical Product Labels and other approval information for FDA-approved drug products can be found at Drugs@FDA, FDA's drug database and DAILYMED, the National Library of Medicines Database.

The following pages discuss new approvals and safety information on drugs approved by the FDA. If you want information about symptoms, causes, treatment, and prevention for over 900 diseases, illnesses, health conditions and wellness issues, you can visit MedlinePlus on the National Institutes of Health's Web site.

Patient Network - Cancer Information

Find out more about new cancer-related drug approvals, and learn what FDA is doing to bring the patient perspective into the review of new drugs to treat or prevent cancer.

Read More

Patient Network Cardiovascular Disease

Learn more about FDA-regulated medications and devices. Keep up-to-date on medical product approvals, recalls and safety information specific to cardiovascular disease.

Read More

Logo Diabetes

Diabetes is the seventh leading cause of death and the number one cause of preventable blindness in the United States. Discover the most recent medical product approvals, stay current on recalls and safety information and menu labeling updates.

Read More

Patient Network Hepatitis B and C

Late breaking information, as well as an archival record of updates on safety and regulatory issues related to Hepatitis B and C.

Read More

Patient Network HIV/AIDS

Learn more about FDA's review and oversight of drugs, biologics and medical devices for the prevention, diagnosis, and treatment of HIV/AIDS and our work to increase access to drugs across the globe.

Read More

 

Page Last Updated: 01/12/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English